Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies

This publication has 52 references indexed in Scilit:

• αvβ6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cells
  Experimental Cell Research, 2005
• Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes
  Journal of Hepatology, 2005
• Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity
  Surgery, 2005
• Matrix metalloproteinase pattern in celiac duodenal mucosa
  Laboratory Investigation, 2005
• Immunohistochemical screening for β₆‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitro
  Histopathology, 2004
• Metabolic Mapping of Proteinase Activity with Emphasis on In Situ Zymography of Gelatinases
  Journal of Histochemistry & Cytochemistry, 2004
• Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema
  Nature, 2003
• Direct integrin αvβ6-ERK binding: implications for tumour growth
  Oncogene, 2002
• Identification of a Sequence within the Integrin β6 Subunit Cytoplasmic Domain That Is Required to Support the Specific Effect of αvβ6 on Proliferation in Three-dimensional Culture
  Published by Elsevier ,1996
• The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain.
  The Journal of cell biology, 1994